Immunogenic peptides and their use in immune disorders
AssigneeDesire Collen Research Foundation vzw
InventorJean-Marie Saint-Remy
Life of this patent
Estimating the term…
Loading patent…
AssigneeDesire Collen Research Foundation vzw
InventorJean-Marie Saint-Remy
Estimating the term…
The present invention provides novel peptides and homologues thereof. The peptides of the invention comprise (i) a T-cell epitope of an antigen (self or non-self) with a potential to trigger an immune reaction presented by a class II major histocompatibility complex (MHC) determinant and recognised by CD4+ T cell more specifically of an allergen or auto-antigen, coupled, optionally through the use of a linker to (ii) an amino acid sequence having a reducing activity, such as a thioreductase sequence. The peptides of the invention have been shown to be useful a medicine, more in particular for the prevention or treatment of immune disorders, more specifically of allergic disorders or autoimmune diseases. The present invention thus provides for the use of said peptides for the manufacture of a medicament for the prevention or treatment of an immune disorder and further provides for methods of treatment or preventing immune disorders by using said peptides. The present invention also provides for compositions comprising said peptides.
1-36. (canceled)
An isolated immunogenic peptide derived from an antigenic protein comprising an artificial sequence comprising:
A method for preparing a peptide of an antigenic protein capable of eliciting cytolytic CD4+ T cell activity said method comprising the steps of:
A method for preparing a peptide of an antigenic protein capable of eliciting cytolytic CD4+ T cell activity said method comprising the steps of:
A method for preparing a peptide of an antigenic protein capable of eliciting cytolytic CD4+ T cell activity said method comprising the steps of:
A method for preparing an isolated immunogenic peptide of an antigenic protein capable of eliciting cytolytic CD4+ T cell activity said method comprising the steps of:
A method of identifying a population of cytotoxic Tregs which comprises determining that, the cells have the following characteristics:
A method of identifying a population of cytotoxic Tregs which comprises determining one or more of the following characteristics, when compared to non-cytotoxic Tregs:
Dependencies are inferred from the claim text.